Literature DB >> 23086140

Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes.

Lucy M Hinder1, Anuradha Vivekanandan-Giri, Lisa L McLean, Subramaniam Pennathur, Eva L Feldman.   

Abstract

Diabetic neuropathy (DN) is the most common complication of diabetes and is characterized by distal-to-proximal loss of peripheral nerve axons. The idea of tissue-specific pathological alterations in energy metabolism in diabetic complications-prone tissues is emerging. Altered nerve metabolism in type 1 diabetes models is observed; however, therapeutic strategies based on these models offer limited efficacy to type 2 diabetic patients with DN. Therefore, understanding how peripheral nerves metabolically adapt to the unique type 2 diabetic environment is critical to develop disease-modifying treatments. In the current study, we utilized targeted liquid chromatography-tandem mass spectrometry (LC/MS/MS) to characterize the glycolytic and tricarboxylic acid (TCA) cycle metabolomes in sural nerve, sciatic nerve, and dorsal root ganglia (DRG) from male type 2 diabetic mice (BKS.Cg-m+/+Lepr(db); db/db) and controls (db/+). We report depletion of glycolytic intermediates in diabetic sural nerve and sciatic nerve (glucose-6-phosphate, fructose-6-phosphate, fructose-1,6-bisphosphate (sural nerve only), 3-phosphoglycerate, 2-phosphoglycerate, phosphoenolpyruvate, and lactate), with no significant changes in DRG. Citrate and isocitrate TCA cycle intermediates were decreased in sural nerve, sciatic nerve, and DRG from diabetic mice. Utilizing LC/electrospray ionization/MS/MS and HPLC methods, we also observed increased protein and lipid oxidation (nitrotyrosine; hydroxyoctadecadienoic acids) in db/db tissue, with a proximal-to-distal increase in oxidative stress, with associated decreased aconitase enzyme activity. We propose a preliminary model, whereby the greater change in metabolomic profile, increase in oxidative stress, and decrease in TCA cycle enzyme activity may cause distal peripheral nerves to rely on truncated TCA cycle metabolism in the type 2 diabetes environment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23086140      PMCID: PMC3665007          DOI: 10.1530/JOE-12-0356

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  54 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

Review 2.  New insights into the mechanisms of diabetic neuropathy.

Authors:  Andrea M Vincent; Eva L Feldman
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

3.  Short-term hyperglycemia produces oxidative damage and apoptosis in neurons.

Authors:  Andrea M Vincent; Lisa L McLean; Carey Backus; Eva L Feldman
Journal:  FASEB J       Date:  2005-01-27       Impact factor: 5.191

4.  Inhibition of Krebs cycle enzymes by hydrogen peroxide: A key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress.

Authors:  L Tretter; V Adam-Vizi
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

5.  Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine.

Authors:  Yunpeng Du; Mark A Smith; Casey M Miller; T S Kern
Journal:  J Neurochem       Date:  2002-03       Impact factor: 5.372

6.  Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.

Authors:  M J Stevens; I Obrosova; X Cao; C Van Huysen; D A Greene
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

Review 7.  Oxidative stress in the pathogenesis of diabetic neuropathy.

Authors:  Andrea M Vincent; James W Russell; Phillip Low; Eva L Feldman
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

8.  Generation of reactive oxygen species in the reaction catalyzed by alpha-ketoglutarate dehydrogenase.

Authors:  Laszlo Tretter; Vera Adam-Vizi
Journal:  J Neurosci       Date:  2004-09-08       Impact factor: 6.167

9.  Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments.

Authors:  Chia-Tung Shun; Yang-Chyuan Chang; Huey-Peir Wu; Song-Chou Hsieh; Whei-Min Lin; Yea-Hui Lin; Tong-Yuan Tai; Sung-Tsang Hsieh
Journal:  Brain       Date:  2004-05-05       Impact factor: 13.501

10.  Digital electron microscopic examination of human sural nerve biopsies.

Authors:  K A Sullivan; M S Brown; L Harmon; D A Greene
Journal:  J Peripher Nerv Syst       Date:  2003-12       Impact factor: 3.494

View more
  42 in total

1.  Long-chain acyl coenzyme A synthetase 1 overexpression in primary cultured Schwann cells prevents long chain fatty acid-induced oxidative stress and mitochondrial dysfunction.

Authors:  Lucy M Hinder; Claudia Figueroa-Romero; Crystal Pacut; Yu Hong; Anuradha Vivekanandan-Giri; Subramaniam Pennathur; Eva L Feldman
Journal:  Antioxid Redox Signal       Date:  2013-10-05       Impact factor: 8.401

2.  Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.

Authors:  Jia-Xin Huang; Yun-Fei Liao; Yu-Ming Li
Journal:  Curr Med Sci       Date:  2019-10-14

Review 3.  Diabetic neuropathy: mechanisms, emerging treatments, and subtypes.

Authors:  James W Albers; Rodica Pop-Busui
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

4.  Chain length of saturated fatty acids regulates mitochondrial trafficking and function in sensory neurons.

Authors:  Amy E Rumora; Giovanni LoGrasso; Julia A Haidar; Justin J Dolkowski; Stephen I Lentz; Eva L Feldman
Journal:  J Lipid Res       Date:  2018-11-15       Impact factor: 5.922

5.  Metabolomic signature of type 1 diabetes-induced sensory loss and nerve damage in diabetic neuropathy.

Authors:  Daniel Rangel Rojas; Rohini Kuner; Nitin Agarwal
Journal:  J Mol Med (Berl)       Date:  2019-04-04       Impact factor: 4.599

Review 6.  Metabolomics in diabetic complications.

Authors:  Laura A Filla; James L Edwards
Journal:  Mol Biosyst       Date:  2016-02-19

Review 7.  Mitochondrial dysfunction in diabetic neuropathy: a series of unfortunate metabolic events.

Authors:  Paul Fernyhough
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

8.  Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story.

Authors:  Lucy M Hinder; Benjamin J Murdock; Meeyoung Park; Diane E Bender; Phillipe D O'Brien; Amy E Rumora; Junguk Hur; Eva L Feldman
Journal:  Exp Neurol       Date:  2018-03-14       Impact factor: 5.330

9.  Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications.

Authors:  Kelli M Sas; Pradeep Kayampilly; Jaeman Byun; Viji Nair; Lucy M Hinder; Junguk Hur; Hongyu Zhang; Chengmao Lin; Nathan R Qi; George Michailidis; Per-Henrik Groop; Robert G Nelson; Manjula Darshi; Kumar Sharma; Jeffrey R Schelling; John R Sedor; Rodica Pop-Busui; Joel M Weinberg; Scott A Soleimanpour; Steven F Abcouwer; Thomas W Gardner; Charles F Burant; Eva L Feldman; Matthias Kretzler; Frank C Brosius; Subramaniam Pennathur
Journal:  JCI Insight       Date:  2016-09-22

10.  Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons.

Authors:  Amy E Rumora; Stephen I Lentz; Lucy M Hinder; Samuel W Jackson; Andrew Valesano; Gideon E Levinson; Eva L Feldman
Journal:  FASEB J       Date:  2017-09-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.